Clinton Capital Partners

Clinton Capital Partners is a Sydney-based boutique corporate advisory and investment firm that arranges bespoke capital raisings for specialized life science and technology companies. Within healthcare, the firm engages with medical device and digital health businesses, often acting as both an advisor structuring the round and an investor participating alongside other funders. This hybrid model differentiates the firm from pure venture funds and means founders typically encounter Clinton Capital both in advisory engagements and as a syndicate participant. Public information about specific fund vehicles and named partner roles is limited.

The firm participates at Seed and Series A with checks typically in the one to five million dollar range, frequently deployed within larger syndicates that include high-net-worth investors, family offices, and other specialized funds. Geographic focus is on Australia, with Sydney as the primary base for client engagements. Founders raising capital who would benefit from structured advisory support, access to a network of Australian sophisticated investors, and tailored round design are the kind of company the firm appears positioned to support, particularly in life sciences and medtech where deal complexity is higher.

Because Clinton Capital operates as both advisor and investor, founders should clarify role expectations and any associated fee or equity structures up front and ensure that advisory and investment functions are appropriately disclosed and aligned. Limited public information about post-investment board engagement and ongoing platform support means founders should rely on references with prior client companies. The firm appears most useful for entrepreneurs who need both a capital partner and a structured intermediary to access Australian high-net-worth and family office capital for complex healthcare rounds.